BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 18266884)

  • 1. The DCC gene and colorectal cancer: the story is more complex.
    Beggs AD; Abulafi M; Hodgson SV
    Colorectal Dis; 2008 Jul; 10(6):630. PubMed ID: 18266884
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlating clinical outcome with molecular events in colorectal cancer.
    Pasricha P
    Gastroenterology; 1997 Jul; 113(1):360-1. PubMed ID: 9207303
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor suppressor genes.
    Anand A
    Hosp Pract (Off Ed); 1993 Jan; 28(1):21. PubMed ID: 8419413
    [No Abstract]   [Full Text] [Related]  

  • 4. DCC expression and prognosis in colorectal cancer.
    Banerjee AK
    Lancet; 1997 Apr; 349(9057):968. PubMed ID: 9100619
    [No Abstract]   [Full Text] [Related]  

  • 5. [Colorectal cancers and molecular biology].
    Grandjouan S
    Pathol Biol (Paris); 1992 Nov; 39(9):904-5. PubMed ID: 1311444
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumor suppressor genes in cancers of colon and rectum].
    Thomas G; Olschwang S; Laurent-Puig P
    Rev Prat; 1991 Nov; 41(23):2313-5. PubMed ID: 1792493
    [No Abstract]   [Full Text] [Related]  

  • 7. [DCC, come back of a suppressor gene in colorectal cancer].
    Broutier L; Castets M
    Med Sci (Paris); 2012 May; 28(5):465-8. PubMed ID: 22642996
    [No Abstract]   [Full Text] [Related]  

  • 8. Should DCC be deleted as tumor-suppressor candidate?
    Gastroenterology; 1997 Jul; 113(1):3. PubMed ID: 9207252
    [No Abstract]   [Full Text] [Related]  

  • 9. No association between the Arg201Gly polymorphism of the DCC gene and colorectal cancer.
    de Jong MM; te Meerman GJ; van der Graaf WT; de Vries EG; Nolte IM; Mulder MJ; Bruinenberg M; van der Steege G; Schaapveld M; Sijmons RH; Hofstra RM; Kleibeuker JH
    Dig Liver Dis; 2004 Dec; 36(12):821-3. PubMed ID: 15646429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DCC: a tumor suppressor gene expressed on the cell surface.
    Hedrick L; Cho KR; Boyd J; Risinger J; Vogelstein B
    Cold Spring Harb Symp Quant Biol; 1992; 57():345-51. PubMed ID: 1339669
    [No Abstract]   [Full Text] [Related]  

  • 11. Congenital mirror movements caused by a mutation in the DCC gene.
    Meneret A; Trouillard O; Brochard V; Roze E
    Dev Med Child Neurol; 2015 Aug; 57(8):776. PubMed ID: 26011025
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel DCC mutation and genetic heterogeneity in congenital mirror movements.
    Djarmati-Westenberger A; Brüggemann N; Espay AJ; Bhatia KP; Klein C
    Neurology; 2011 Oct; 77(16):1580. PubMed ID: 22006891
    [No Abstract]   [Full Text] [Related]  

  • 13. [Familial colorectal cancer type X: clinical, pathological and molecular characterization].
    Ferreira S; Lage P; Sousa R; Claro I; Francisco I; Filipe B; Suspiro A; Chaves P; Rodrigues P; Albuquerque C; Nobre Leitão C
    Acta Med Port; 2009; 22(3):207-14. PubMed ID: 19686620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the molecular mechanisms for dedifferentiation at the invasion front of colorectal cancer by a gene expression analysis.
    Oku Y; Shimoji T; Takifuji K; Hotta T; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Nasu T; Tamura K; Matsuura M; Miyata S; Kato Y; Yamaue H; Miki Y
    Clin Cancer Res; 2008 Nov; 14(22):7215-22. PubMed ID: 19010838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of multifactor dimensionality reduction on the interactions between gene-gene, gene-environment and the risk sporadic colorectal cancer in Chinese population].
    Jin MJ; Liu B; Zhang SS; Zhang YJ; Xu M; Ma XY; Yao KY; Chen K
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):535-9. PubMed ID: 19040031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
    Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predisposition to colorectal cancer: exploiting copy number variation to identify novel predisposing genes and mechanisms.
    Venkatachalam R; Ligtenberg MJ; Hoogerbrugge N; Geurts van Kessel A; Kuiper RP
    Cytogenet Genome Res; 2008; 123(1-4):188-94. PubMed ID: 19287155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer.
    Sato T; Oshima T; Yoshihara K; Yamamoto N; Yamada R; Nagano Y; Fujii S; Kunisaki C; Shiozawa M; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2009 Jan; 21(1):211-6. PubMed ID: 19082464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression signature for recurrence in stage III colorectal cancers.
    Watanabe T; Kobunai T; Sakamoto E; Yamamoto Y; Konishi T; Horiuchi A; Shimada R; Oka T; Nagawa H
    Cancer; 2009 Jan; 115(2):283-92. PubMed ID: 19016304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.